NanoVibronix, Inc. (NAOV) |
|
0.3139 0 (0.1%)
|
01-27 15:58 |
|
Open: |
0.310001 |
Pre. Close: |
0.3136 |
|
High:
|
0.32 |
Low:
|
0.3 |
|
Volume:
|
83,633 |
Market Cap:
|
10(M) |
|
|
|
Technical analysis |
as of: 2023-01-27 4:46:30 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 0.44 One year: 0.51 |
| Support: |
Support1: 0.28 Support2: 0.21 |
| Resistance: |
Resistance1: 0.37 Resistance2: 0.44 |
| Pivot: |
0.32  |
| Moving Average: |
MA(5): 0.31  MA(20): 0.3
MA(100): 0.37 MA(250): 0.58 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 49.5 %D(3): 52.4 |
| RSI: |
RSI(14): 49.1 |
| 52-week: |
High: 1.36 Low: 0.21 |
| Average Vol(K): |
3-Month: 1,359 (K) 10-Days: 125 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ NAOV ] has closed above bottom band by 39.8%. Bollinger Bands are 49.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.32 - 0.32 |
0.32 - 0.32 |
|
Low:
|
0.3 - 0.3 |
0.3 - 0.3 |
|
Close:
|
0.31 - 0.31 |
0.31 - 0.32 |
|
Company Description |
|
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York. |
Headline News |
Thu, 26 Jan 2023
NanoVibronix, Inc. (NAOV) Stock Price Today, Quote & News - Seeking Alpha
Wed, 11 Jan 2023
Is NanoVibronix Inc (NAOV) Stock a Smart Value? - InvestorsObserver
Thu, 15 Dec 2022
NanoVibronix Announces Results of Annual Meeting of ... - Business Wire
Tue, 13 Dec 2022
NanoVibronix Announces Partnership with Peak Medical, Ltd. - Business Wire
Fri, 09 Dec 2022
Most Shareholders Will Probably Find That The Compensation For NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Is Reasonable - Simply Wall St
Mon, 28 Nov 2022
NAOV stock jumps on FDA nod for ultrasound pain therapy device ... - Seeking Alpha
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
33 (M) |
| Shares Float |
28 (M) |
|
% Held by Insiders
|
0.4 (%) |
|
% Held by Institutions
|
4.5 (%) |
|
Shares Short
|
322 (K) |
|
Shares Short P.Month
|
489 (K) |
Stock Financials |
|
EPS
|
-0.41 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0.1 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-357 |
|
Return on Assets (ttm)
|
-48.9 |
|
Return on Equity (ttm)
|
-98.9 |
|
Qtrly Rev. Growth
|
-80.6 |
|
Gross Profit (p.s.)
|
0.02 |
|
Sales Per Share
|
0.04 |
|
EBITDA (p.s.)
|
-0.18 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-7 (M) |
|
Levered Free Cash Flow
|
-4 (M) |
Stock Valuations |
|
PE Ratio
|
-0.79 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
2.85 |
|
Price to Sales
|
6.31 |
|
Price to Cash Flow
|
-1.57 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
